EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)ÄquivalenzstudieMultizentrische StudieOpen Access

One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis

Edward W Hook, Jodie A Dionne, Kimberly Workowski, Candice J McNeil, Stephanie N Taylor, Teresa A Batteiger, Julia C Dombrowski, Kenneth H Mayer, Arlene C Seña, Matthew M Hamill iD, Harold C Wiesenfeld, Chunming Zhu und 3 weitere

New England Journal of Medicine · 04.09.2025 · 393 (9) · 869-878

DOI: 10.1056/nejmoa2401802 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 04.09.2025. Verfasst von Edward W Hook und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alabama at Birmingham, Birmingham. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Penicillin G Benzathine, Syphilis, Syphilis Serodiagnosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPenicillin G BenzathineSyphilisSyphilis SerodiagnosisAdultFemaleHumansMaleMiddle AgedYoung AdultDrug Administration ScheduleHIV InfectionsInjections, IntramuscularReaginsTreponema pallidumAged

Substanzen

Anti-Bacterial AgentsPenicillin G BenzathineReagins

Autor:innen und Institutionen

  • Department of Medicine, University of Alabama at Birmingham, Birmingham.
  • Department of Medicine, Emory University, Atlanta.
  • Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC.
  • Department of Medicine, Louisiana State University, New Orleans.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis.
  • Department of Medicine, University of Washington, Seattle.

ORCID-Profile: Matthew M Hamill

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hook, E. W., Dionne, J. A., Workowski, K., McNeil, C. J., Taylor, S. N., Batteiger, T. A., Dombrowski, J. C., Mayer, K. H., Seña, A. C., Hamill, M. M., Wiesenfeld, H. C., Zhu, C., Perlowski, C., Mejia-Galvis, J. E., & Newman, L. M. (2025). One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis. New England Journal of Medicine, 393(9), 869-878. https://doi.org/10.1056/nejmoa2401802

Vancouver

Hook EW, Dionne JA, Workowski K, McNeil CJ, Taylor SN, Batteiger TA, et al. One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis. New England Journal of Medicine. 2025;393(9):869-878. doi:10.1056/nejmoa2401802

BibTeX
@article{Hook2025,
  author = {Hook, Edward W and Dionne, Jodie A and Workowski, Kimberly and McNeil, Candice J and Taylor, Stephanie N and Batteiger, Teresa A and Dombrowski, Julia C and Mayer, Kenneth H and Seña, Arlene C and Hamill, Matthew M and Wiesenfeld, Harold C and Zhu, Chunming and Perlowski, Charlotte and Mejia-Galvis, Jorge E and Newman, Lori M},
  title = {One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {9},
  pages = {869--878},
  doi = {10.1056/nejmoa2401802}
}
Kostenlos starten →